Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
grade A 43.27 1.76% 0.75
GSK closed up 1.76 percent on Wednesday, October 23, 2019, on 1.53 times normal volume. The bulls were able to push the stock to a new 52-week high. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical GSK trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
BB Squeeze Ended Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 1.76%

Older signals for GSK ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Energy Medicine Health Cancer Pharmaceutical Drugs Infectious Diseases Medication Pharmaceutical Products Rare Diseases Influenza Asthma HIV Nutrition Products Antibiotic Depression Infections Wellness Products Oral Care Products Fever Smoking Cessation Eczema Glaxosmithkline Consumer Health Products Hepatitis A Joint Pain Measles Mumps Nicotine Preventive Healthcare Rubella Tetanus
Is GSK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 43.31
52 Week Low 36.41
Average Volume 2,185,361
200-Day Moving Average 40.6336
50-Day Moving Average 41.6076
20-Day Moving Average 42.235
10-Day Moving Average 42.454
Average True Range 0.5239
ADX 13.26
+DI 32.9756
-DI 19.9823
Chandelier Exit (Long, 3 ATRs ) 41.7383
Chandelier Exit (Short, 3 ATRs ) 42.4017
Upper Bollinger Band 43.0848
Lower Bollinger Band 41.3852
Percent B (%b) 1.11
BandWidth 4.024151
MACD Line 0.3256
MACD Signal Line 0.2594
MACD Histogram 0.0662
Fundamentals Value
Market Cap 105.76 Billion
Num Shares 2.44 Billion
EPS 1.03
Price-to-Earnings (P/E) Ratio 42.01
Price-to-Sales 2.27
Price-to-Book 83.56
PEG Ratio 1.10
Dividend 1.99
Dividend Yield 4.60%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 43.80
Resistance 3 (R3) 43.75 43.53 43.71
Resistance 2 (R2) 43.53 43.40 43.55 43.68
Resistance 1 (R1) 43.40 43.31 43.47 43.45 43.65
Pivot Point 43.18 43.18 43.21 43.20 43.18
Support 1 (S1) 43.05 43.05 43.12 43.10 42.89
Support 2 (S2) 42.83 42.96 42.85 42.86
Support 3 (S3) 42.70 42.83 42.83
Support 4 (S4) 42.75